(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 9. Increased tumor formation in Inv-Dsg2 transgenic mice. (A,B) Histological analysis of epidermal hyperplasia and early forms of papillomas in Inv-Dsg2 transgenic but not control wild-type mice at 6 weeks (A) and 3 months (B) (10x magnification). Arrows indicate hyperproliferation; box, hyperkeratosis; asterisk, encapsulated stratum corneum. (C) After 25 weeks of DMBA and TPA treatment, the Inv-Dsg2 transgenic mice developed more tumors than control wild-type mice. (D,E) The frequency and average number of papillomas in wild-type and transgenic mice after 25 weeks of tumor promotion. For tumors greater than 2 mm, *P=0.0063. (F) Histopathological appearance of carcinogen-induced tumors from wild-type and transgenic mice showing differentiated and hyperkeratotic papillomas.